AZD4625
AZD4625 is a potent, selective, and orally bioavailable covalent inhibitor targeting the oncogenic mutant KRAS G12C. It demonstrates activity in both cellular assays and in vivo models, supporting its use in cancer research, particularly for studying targeted therapies in KRAS-driven tumors.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Molecular Formula
C24H21ClF2N4O3
Molecular Weight
486.9
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog